In Vitro ADME
Performing early in vitro ADME test is a way to better understand the absorption, distribution,
mode of
action (MOA) metabolism, excretion (ADME) and pharmacokinetic (PK) properties of a compound. These
properties are very critical for selecting the proper drug candidates for later experiments.
Creative Biolabs offers a comprehensive range of tailored in vitro ADME services, including professional testing design, GLP-based in vitroADME testing and data analysis, to help you characterize the ADME properties of your drug candidate and its interaction function. Our high-throughput ADME screening platforms provide rapid and efficient testing capabilities to ensure the highest level of precision, reproducibility, and consistency in our results. Our experienced team has strong problem-solving skills that enable us to perform a variety of in vitro ADME screening tests and assist clients to come up with a solution that suits their drug discovery needs.
Our Complete Suite of In Vitro ADME Services Includes:
Distribution
-
CaCo-2 & MDCK Permeability
-
PAMPA (GIT, BBB and Skin)
-
Influx Transporters
-
Plasma / Blood Partitioning
-
Blood Brain Barrier Penetration
Others
-
Cell Proliferation & Cytoxicity
-
Mechanism PK Study
-
In Vitro Toxicity
-
hERG Inhibition
Highlights at Creative Biolabs:
-
Guarantee: further action will only be taken when the previous step is succeeding.
-
A wide range of solutions: we have come up with a complete pipeline to provide you with flexible options.
-
State-of-the-art equipment: your project deserves the best equipment in the field.
Creative Biolabs's years of expertise and propriety LC-MS-MS-based technologies enable us to gain insight
into your ADME analysis development, accelerate your data collection, and help you interpret the results.
We are devoted to accelerating and enhancing your drug discovery, allowing you to identify the most
promising hit compounds for next immunotherapy-based cancer treatment.
For more information, please contact us.
For Research Use Only | Not For Clinical Use
Related Services